KENNEY CHRISTOPHER JOHN
SEC CIK 1880129 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | Chief Medical Off | 2 | $20.2K | $694.8K | 7 | 2022-01-21 | 2026-08-28 |
Most active insiders at XENE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORTIMER IAN | Pres, CEO, INTERIM CFO, Dir | — | $21.30M |
| 2 | KENNEY CHRISTOPHER JOHN | Chief Medical Off | — | $670.3K |
| 3 | GANNON STEVEN | Dir | — | $640.6K |
| 4 | DiFabio Andrea | CLO | — | $230.8K |
| 5 | PATOU GARY | Dir | — | $70.3K |
| 6 | Cannon Gillian | Dir | — | $63.2K |
| 7 | GAROFALO ELIZABETH A. | Dir | — | — |
| 8 | Gover Justin D. | Dir | — | — |
| 9 | Svoronos Dawn | Dir | — | — |
| 10 | Machado Patrick | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-31 21:59 | 2026-08-28 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | S - Sale | $60.25 | -7,068 | 2 | -100% | -$425.8K |
| DT | 2026-03-13 | 2026-03-12 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | M - OptEx | — | +3,750 | 8,479 | +79% | — |
| DT | 2026-03-13 | 2026-03-13 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | S - Sale+OE | $55.23 | -1,410 | 7,069 | -17% | -$77.9K |
| DT | 2026-03-11 | 2026-03-09 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | M - OptEx | — | +7,500 | 7,500 | New | — |
| DT | 2026-03-11 | 2026-03-10 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | S - Sale+OE | $60.11 | -2,771 | 4,729 | -37% | -$166.6K |
| 2023-03-24 | 2023-03-24 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | S - Sale | $35.01 | -700 | 0 | -100% | -$24.5K | |
| 2022-01-21 | 2022-01-21 | XENE | Xenon Pharmaceuticals Inc. | KENNEY CHRISTOPHER JOHN | Chief Medical Off | P - Purchase | $28.81 | +700 | 700 | New | +$20.2K |
Purchase Sale Sale after option exercise All abbreviations